Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

NCT01447225 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: MM-121
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Cabazitaxel
DRUG: Gemcitabine

Sponsor

Merrimack Pharmaceuticals

Collaborators

[object Object]